Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-669
Closed -$49K 185
2021
Q1
$49K Buy
669
+160
+31% +$11.8K 0.07% 76
2020
Q4
$40K Buy
509
+107
+27% +$8.18K 0.06% 89
2020
Q3
$32K Buy
+402
New +$31.5K 0.05% 79
2020
Q2
Sell
-2,895
Closed -$213K 41
2020
Q1
$213K Sell
2,895
-891
-24% -$70K 0.4% 35
2019
Q4
$312K Buy
+3,786
New +$311K 0.29% 46

Other funds holding MRK

Fiduciary Planning's MRK Position: Q2 2021 in Review

Fiduciary Planning sold out of Merck (MRK) in Q2 2021, closing a stake of 669 shares — an estimated $49K sold.

Fiduciary Planning first reported a position in MRK in Q4 2019 and held it in 5 quarters. The position peaked at $312K in Q4 2019. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • Fiduciary Planning reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
  • Fiduciary Planning sold 669 Merck shares in Q2 2021, an estimated $49K.
  • Fiduciary Planning first reported a position in Merck in Q4 2019 and held it in 5 quarters.
  • Fiduciary Planning's Merck position peaked at $312K in Q4 2019.
  • 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Fiduciary Planning's 13F filing for Q2 2021, filed 6 Aug 2021.